Summary
The Alfred Mann Foundation (AMF) is a medical institute that develops medical devices and commercializes solutions for significant medical conditions. The institute conducts research in the therapeutic areas of neuromuscular disorders, diabetes, limb loss, chronic pain, and others. It offers neurostimulator, implant, microstimulator devices, and others. AMF offers biomedical engineering, innovation, research and development and clinical trials, among others. The institute developes technology to combine an insulin-delivery system with a blood glucose monitor to create an automated implantable device that could replicate the blood-glucose control ability of the human pancreas. It offers treatments for diabetes, movement disorders, limb loss, pain, and others. AMF is headquartered in Los Angeles, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Reasons to Buy:
Note: Some sections may be missing if data is unavailable for the company
The Alfred Mann Foundation (AMF) is a medical institute that develops medical devices and commercializes solutions for significant medical conditions. The institute conducts research in the therapeutic areas of neuromuscular disorders, diabetes, limb loss, chronic pain, and others. It offers neurostimulator, implant, microstimulator devices, and others. AMF offers biomedical engineering, innovation, research and development and clinical trials, among others. The institute developes technology to combine an insulin-delivery system with a blood glucose monitor to create an automated implantable device that could replicate the blood-glucose control ability of the human pancreas. It offers treatments for diabetes, movement disorders, limb loss, pain, and others. AMF is headquartered in Los Angeles, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company The Alfred Mann Foundation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
The Alfred Mann Foundation Company Overview
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- The Broad Foundation
- Nebraska Heart Institute
- Foundation Radiology Group PC
- Dystonia Medical Research Foundation
- Central Illinois Radiological Associates Ltd
